Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |